Related Experiment Video
Updated: Mar 22, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
We Give Aminoglycoside Antibiotics at the End of Hemodialysis
1Department of Pharmacy Practice, University of Connecticut, Storrs, Connecticut.
Abstract:
We often administer dialyzable medications after dialysis to ensure that adequate concentrations are maintained in the body until the next session. In the case of aminoglycosides, we may have the opportunity to dose more aggressively predialysis, and then use the clearance of the drug by dialysis to limit toxicities. Predialysis aminoglycoside dosing is intriguing, although studies evaluating the safety and efficacy of this approach are necessary before it can be used routinely.
More Related Videos
Related Concept Videos
Estimation of k and VD of Aminoglycosides
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Inhibitors of Bacterial Protein Synthesis
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Hemodialysis III: Nursing Management

